1
|
Alrubaye RR, Fadel CA, Adewunmi CY, Del Rio Lopez L. Pleural Effusion Secondary to Dasatinib Following Allogenic Hematopoietic Stem Cell Transplantation. AMERICAN JOURNAL OF CASE REPORTS 2021; 22:e932711. [PMID: 34362863 PMCID: PMC8363658 DOI: 10.12659/ajcr.932711] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Patient: Male, 72-year-old
Final Diagnosis: Dasatinib induced pleural effusion
Symptoms: Cough • shortness of breath
Medication: —
Clinical Procedure: Chest computed tomography • chest xray • thoracentesis
Specialty: Hematology • General and Internal Medicine • Oncology • Pulmonology
Collapse
Affiliation(s)
- Riyadh R Alrubaye
- Department of Hospital Medicine, North East Georgia Health System, Gainsvellie, GA, USA
| | - Celine A Fadel
- Graduate Medical Education, Internal Medicine Residency Program, North East Georgia Health System, Gainsvellie, GA, USA
| | - Comfort Y Adewunmi
- Graduate Medical Education, Internal Medicine Residency Program, North East Georgia Health System, Gainsvellie, GA, USA
| | - Loida Del Rio Lopez
- Graduate Medical Education, Internal Medicine Residency Program, North East Georgia Health System, Gainsvellie, GA, USA
| |
Collapse
|
2
|
Kim M, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Shin S, Kim YH, Ha HS, Hong JJ, Kim IO, Han DJ, Lee SG. Simultaneous liver-kidney transplantation: A single-center experience in Korea. Ann Hepatobiliary Pancreat Surg 2020; 24:454-459. [PMID: 33234748 PMCID: PMC7691209 DOI: 10.14701/ahbps.2020.24.4.454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2020] [Revised: 09/11/2020] [Accepted: 09/13/2020] [Indexed: 12/02/2022] Open
Abstract
BACKGROUNDS/AIMS Simultaneous liver and kidney transplantation (SLKT) has been established as the treatment of choice for patients with concurrent end-stage liver and end-stage kidney diseases. The objective of this study was to analyze the nationwide incidence of SLKT in Korea and the outcomes of SLKT in a high-volume transplant center. METHODS Databases of the Korean Network for Organ Sharing (KONOS) and Asan Medical Center from 2000 to 2019 were retrospectively reviewed to determine the incidence of SLKT. RESULTS During 20 years from 2000 to 2019, deceased donor SLKT was performed for 38 cases in the KONOS database. The proportion of deceased donor SLKT was 0.6% (20 of 3333) before adoption of MELD score, which was significantly increased to 1.2% (18 of 1524) after the adoption of MELD score (p=0.034). In our institution, there were 11 cases of SLKT (2 cases with deceased donors and 9 cases with living donors). SLKT accounted for 0.2% (11 of 6468) of total liver transplantation volume. During follow-up, five patients died due to hepatocellular carcinoma recurrence (n=2), infection (n=2), or unknown cause (n=1). The 1-year and 10-year overall patient survival rates were 90.9% and 81.8%, respectively. CONCLUSIONS Results of this study revealed that the incidence of deceased donor SLKT was very low. An increase of such incidence is not anticipated unless the number of deceased donors is markedly increased. Currently, sequential living donor liver transplantation and kidney transplantation with deceased or living donors are mainstays of transplantation rather than SLKT in our institution.
Collapse
Affiliation(s)
- Minjae Kim
- Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Shin Hwang
- Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Chul-Soo Ahn
- Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Deok-Bog Moon
- Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Tae-Yong Ha
- Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Gi-Won Song
- Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Dong-Hwan Jung
- Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Sung Shin
- Division of Kidney and Pancreas Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Young Hoon Kim
- Division of Kidney and Pancreas Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Hea-Seon Ha
- Organ Transplantation Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Jung-Ja Hong
- Organ Transplantation Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - In-Ok Kim
- Organ Transplantation Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Duck Jong Han
- Division of Kidney and Pancreas Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| | - Sung-Gyu Lee
- Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea
| |
Collapse
|